Valuation
- Market cap
- 208,000
- Revenue TTM
- $0
- Net income TTM
- $-8,630,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 300
- Avg volume
- 2,082
- Day's range
- $0.18 – $0.18
- Shares out
- 1,135,000
- Stochastic %K
- 28%
- Beta
- 5.96
- Analysts
- —
- Price target
- $44.98
Company profile
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 720 437 6500
- Website
- https://ampiopharma.com
- Address
- 9800 Mount Pyramid Court, Suite 400, Englewood, United States
Latest news
No headlines yet.
